CC
ARRY

Carlson Capital’s Array Biopharma Inc ARRY Stock Holding History

Carlson Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-947,234
Closed -$43.9M – 306
2019
Q2 		$43.9M Buy
+947,234
New +$26.6M 0.66% 33

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Carlson Capital's ARRY Position: Q3 2019 in Review

Carlson Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 947,234 shares — an estimated $43.9M sold.

Carlson Capital first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $43.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Carlson Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Carlson Capital sold 947,234 Array Biopharma Inc shares in Q3 2019, an estimated $43.9M.
  • Carlson Capital first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Carlson Capital's Array Biopharma Inc position peaked at $43.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Carlson Capital's 13F filing for Q3 2019, filed 13 Nov 2019.